Typhoid Vi capsular polysaccharide tetanus toxoid protein conjugate vaccine (Bharat Biotech)

N/A

Report date: 2022/01/14 13:23:58

Base Information

Drug NameTyphoid Vi capsular polysaccharide tetanus toxoid protein conjugate vaccine (Bharat Biotech)
Drug Alias NameTyphoid Vi capsular polysaccharide tetanus toxoid protein conjugate vaccine (Typbar-TCV) - BBIL伤寒Vi荚膜多糖破伤风毒素蛋白结合疫苗（Bharat Biotech）Typhoid Vi capsular polysaccharide-tetanus toxoid conjugate vaccine (Typbar TCV) - Bharat BiotechTyphoid conjugate vaccine (Typbar-TCV) - Bharat BiotechTyphoid Vi polysaccharide-TT conjugate vaccine - Bharat Biotech +[6] 
ClassificationVaccines > Biological material > Toxoid vaccineVaccines > Development/production technology > Conjugated vaccineVaccines > Biological material > Bacterial vaccine +[4] 
Mechanisms of ActionImmunostimulants
TargetsNot applicable
Therapy Area/IndicationsTyphoid Fever
Global Approved IndicationsTyphoid Fever
Approved Indications in ChinaN/A
Original Approved Country/TerritoryIndia
Original Approved Date2013/08/26
Country/TerritoryPhilippinesBangladeshUnited Kingdom +[4] 
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaN/A
Originator CompaniesBharat Biotech International Ltd
China Registration ClassN/A

Develop Information

Active CompaniesUniversity Of OxfordBharat Biotech International LtdEubiologics Co Ltd
Inactive CompaniesN/A
Active IndicationsTyphoid Fever
Inactive IndicationsN/A

Other Information

ATC CodeJ07AP
Related LinksN/A